73655-44-4Relevant academic research and scientific papers
KCNT1 INHIBITORS AND METHODS OF USE
-
Paragraph 000353, (2020/11/23)
The present invention is directed to, in part, compounds and compositions useful for preventing and/or treating a neurological disease or disorder, a disease or condition relating to excessive neuronal excitability, and/or a gain-of-function mutation in a gene (e.g., KCNT1). Methods of treating a neurological disease or disorder, a disease or condition relating to excessive neuronal excitability, and/or a gain-of-function mutation in a gene such as KCNT1 are also provided herein.
SULFOXIMINE DERIVATIVES AS FACTOR XA INHIBITORS
-
Page/Page column 1, (2011/04/18)
The present invention relates to novel substituted sulfoximine derivatives of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their pre
